Table 3 Haemolytic C activities and C activation product levels in AF samples
Diagnosis | Sample no. | CH100CL (U ml−1) | CH100AP (% normal) | C3a (ng ml−1) | SC5b-9 (ng ml−1) |
|---|---|---|---|---|---|
Ovarian cancer | 1 | <25 | 35 | 5100 | 2546 |
2 | 40 | 95 | 2750 | 11996 | |
3 | 60 | 115 | 1800 | 20211 | |
4 | 100 | 80 | 3600 | 18928 | |
5 | 100 | 100 | 3600 | 12414 | |
6 | <25 | 95 | 1500 | 1511 | |
7 | <25 | 80 | 1100 | <10 | |
8 | 100 | 100 | 2000 | 2575 | |
9 | 140 | 100 | 3000 | 4049 | |
10 | 90 | 70 | 1375 | 2955 | |
11 | 70 | 40 | 1000 | <10 | |
12 | 80 | 120 | 3800 | 4067 | |
Mean±s.d. | 68.13±41.53 | 85.83±26.61 | 2552±1292 | 6771±7208 | |
Other gynaecological neoplasms | 13 | 70 | 65 | 2750 | <10 |
14 | <25 | 50 | 6300 | 2946 | |
15 | 90 | 60 | 7300 | 12659 | |
16 | <25 | 65 | 3500 | 12307 | |
Liver failure | 17 | <25 | — | 240 | 2493 |
18 | <25 | — | 1200 | 1133 | |
Serum/range | 50–100 | 66–129 | |||
Plasma/range | 26–146 | <100 |
